These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17280595

  • 21. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 22. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 23. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
    Haefner S, Baghai TC, Schule C, Eser D, Spraul M, Zill P, Rupprecht R, Bondy B.
    Neuropsychobiology; 2008 Jun 15; 58(3-4):154-62. PubMed ID: 19088492
    [Abstract] [Full Text] [Related]

  • 24. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, Dose T, Wollweber B, Spieler D, Messer T, Lutz R, Künzel H, Bierner T, Pollmächer T, Pfister H, Nickel T, Sonntag A, Uhr M, Ising M, Holsboer F, Lucae S.
    J Psychiatr Res; 2009 Jan 15; 43(3):215-29. PubMed ID: 18586274
    [Abstract] [Full Text] [Related]

  • 25. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression.
    Heuser I.
    Pharmacopsychiatry; 1998 Jan 15; 31(1):10-3. PubMed ID: 9524978
    [Abstract] [Full Text] [Related]

  • 26. Flavonoids of St. John's Wort reduce HPA axis function in the rat.
    Butterweck V, Hegger M, Winterhoff H.
    Planta Med; 2004 Oct 15; 70(10):1008-11. PubMed ID: 15490333
    [Abstract] [Full Text] [Related]

  • 27. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 15; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 28. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.
    Zobel AW, Schulze-Rauschenbach S, von Widdern OC, Metten M, Freymann N, Grasmäder K, Pfeiffer U, Schnell S, Wagner M, Maier W.
    J Psychiatr Res; 2004 Nov 15; 38(4):377-83. PubMed ID: 15203289
    [Abstract] [Full Text] [Related]

  • 29. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM, Mullen BC, Schatzberg AF.
    Psychoneuroendocrinology; 2007 Nov 15; 32(8-10):859-64. PubMed ID: 17666187
    [Abstract] [Full Text] [Related]

  • 30. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T, Ising M, Erbe S, Winkelmann P, Ritter D, Uhr M, Lewitzka U.
    J Psychiatr Res; 2012 Jan 15; 46(1):111-7. PubMed ID: 22030468
    [Abstract] [Full Text] [Related]

  • 31. Bioactive compounds from Paecilomyces tenuipes regulating the function of the hypothalamo-hypophyseal system axis in chronic unpredictable stress rats.
    Yin YY, Ming L, Zheng LF, Kan HW, Li CR, Li WP.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1088-92. PubMed ID: 17637227
    [Abstract] [Full Text] [Related]

  • 32. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
    Lizcano F, Salvador J.
    Clin Exp Pharmacol Physiol; 2008 Sep 20; 35(9):1085-90. PubMed ID: 18505442
    [Abstract] [Full Text] [Related]

  • 33. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec 20; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender.
    Hatzinger M, Brand S, Herzig N, Holsboer-Trachsler E.
    J Psychiatr Res; 2011 Oct 20; 45(10):1373-80. PubMed ID: 21641616
    [Abstract] [Full Text] [Related]

  • 36. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA, Ribeiro SC.
    Brain Res; 2006 Dec 18; 1126(1):148-55. PubMed ID: 16824495
    [Abstract] [Full Text] [Related]

  • 37. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.
    J Affect Disord; 2007 Dec 18; 104(1-3):83-90. PubMed ID: 17467808
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.